TuHURA Biosciences (HURA) earnings
In the quarter ended June 2026, TuHURA Biosciences had revenue of —, and diluted EPS of -0.14.
On August 14, 2026 it reported EPS of -0.14 against an estimate of -0.15 (beat).
The next report is expected on Friday, November 13, 2026, with EPS expected around -0.14.
Report dates
| Report | Date | Time | EPS estimate | EPS reported |
|---|---|---|---|---|
| Next | Fri Nov 13, 2026 | — | -0.14 | — |
| Last | Fri Aug 14, 2026 | — | -0.15 | -0.14 |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Quarterly results
The last 12 quarters from TuHURA Biosciences's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | — | — | -0.14 | — | — | 2026-08-14 |
| Mar 31, 2026 | $0 | — | -0.13 | — | — | 2026-05-15 |
| Dec 31, 2025 | $0 | — | — | — | — | 2026-03-31 |
| Sep 30, 2025 | $0 | — | -0.14 | — | — | 2025-11-14 |
| Jun 30, 2025 | $0 | — | -0.21 | — | — | 2025-08-14 |
| Mar 31, 2025 | $0 | — | -0.15 | — | — | 2025-05-15 |
| Dec 31, 2024 | $0 | — | — | — | — | 2025-03-31 |
| Sep 30, 2024 | $0 | — | -0.54 | — | — | 2024-11-14 |
| Jun 30, 2024 | $0 | — | -0.43 | — | — | 2025-08-14 |
| Mar 31, 2024 | $0 | — | -0.40 | — | — | 2024-05-14 |
| Dec 31, 2023 | — | — | -0.24 | — | — | 2024-02-14 |
| Sep 30, 2023 | — | — | -63.92 | — | — | 2023-11-13 |
Questions
When does TuHURA Biosciences report earnings?
TuHURA Biosciences's next earnings report is expected on November 13, 2026.
How did TuHURA Biosciences do last quarter?
In the quarter ended June 2026, TuHURA Biosciences had revenue of —, and diluted EPS of -0.14.
From TuHURA Biosciences's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.